146 related articles for article (PubMed ID: 33168683)
1. Cancer-Specific Mortality, All-Cause Mortality, and Overdiagnosis in Lung Cancer Screening Trials: A Meta-Analysis.
Ebell MH; Bentivegna M; Hulme C
Ann Fam Med; 2020 Nov; 18(6):545-552. PubMed ID: 33168683
[TBL] [Abstract][Full Text] [Related]
2. Overdiagnosis in low-dose computed tomography screening for lung cancer.
Patz EF; Pinsky P; Gatsonis C; Sicks JD; Kramer BS; Tammemägi MC; Chiles C; Black WC; Aberle DR;
JAMA Intern Med; 2014 Feb; 174(2):269-74. PubMed ID: 24322569
[TBL] [Abstract][Full Text] [Related]
3. Effects of low-dose computed tomography on lung cancer screening: a systematic review, meta-analysis, and trial sequential analysis.
Huang KL; Wang SY; Lu WC; Chang YH; Su J; Lu YT
BMC Pulm Med; 2019 Jul; 19(1):126. PubMed ID: 31296196
[TBL] [Abstract][Full Text] [Related]
4. Impact of annual trend volume of low-dose computed tomography for lung cancer screening on overdiagnosis, overmanagement, and gender disparities.
Hsin-Hung C; En-Kuei T; Yun-Ju W; Fu-Zong W
Cancer Imaging; 2024 Jun; 24(1):73. PubMed ID: 38867342
[TBL] [Abstract][Full Text] [Related]
5. Do we know enough about the effect of low-dose computed tomography screening for lung cancer on mortality to act? An updated systematic review, meta-analysis and network meta-analysis of randomised controlled trials 2017 to 2021.
Duer E; Yang H; Robinson S; Grigore B; Sandercock J; Snowsill T; Griffin E; Peters J; Hyde C
Diagn Progn Res; 2023 Dec; 7(1):26. PubMed ID: 38072977
[TBL] [Abstract][Full Text] [Related]
6. Identifying Patients for Whom Lung Cancer Screening Is Preference-Sensitive: A Microsimulation Study.
Caverly TJ; Cao P; Hayward RA; Meza R
Ann Intern Med; 2018 Jul; 169(1):1-9. PubMed ID: 29809244
[TBL] [Abstract][Full Text] [Related]
7. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.
Pastorino U; Silva M; Sestini S; Sabia F; Boeri M; Cantarutti A; Sverzellati N; Sozzi G; Corrao G; Marchianò A
Ann Oncol; 2019 Jul; 30(7):1162-1169. PubMed ID: 30937431
[TBL] [Abstract][Full Text] [Related]
8. Low-Dose Computed Tomography (LDCT) Lung Cancer Screening in Asian Female Never-Smokers Is as Efficacious in Detecting Lung Cancer as in Asian Male Ever-Smokers: A Systematic Review and Meta-Analysis.
Triphuridet N; Zhang SS; Nagasaka M; Gao Y; Zhao JJ; Syn NL; Hanaoka T; Ou SI; Shum E
J Thorac Oncol; 2023 Jun; 18(6):698-717. PubMed ID: 36775191
[TBL] [Abstract][Full Text] [Related]
9. Assessing Lung Cancer Absolute Risk Trajectory Based on a Polygenic Risk Model.
Hung RJ; Warkentin MT; Brhane Y; Chatterjee N; Christiani DC; Landi MT; Caporaso NE; Liu G; Johansson M; Albanes D; Marchand LL; Tardon A; Rennert G; Bojesen SE; Chen C; Field JK; Kiemeney LA; Lazarus P; Zienolddiny S; Lam S; Andrew AS; Arnold SM; Aldrich MC; Bickeböller H; Risch A; Schabath MB; McKay JD; Brennan P; Amos CI
Cancer Res; 2021 Mar; 81(6):1607-1615. PubMed ID: 33472890
[TBL] [Abstract][Full Text] [Related]
10. Low-dose computed tomography screening for lung cancer in populations highly exposed to tobacco: A systematic methodological appraisal of published randomised controlled trials.
Coureau G; Salmi LR; Etard C; Sancho-Garnier H; Sauvaget C; Mathoulin-Pélissier S
Eur J Cancer; 2016 Jul; 61():146-56. PubMed ID: 27211572
[TBL] [Abstract][Full Text] [Related]
11. The influence of postscreening follow-up time and participant characteristics on estimates of overdiagnosis from lung cancer screening trials.
Li M; Zhang L; Charvat H; Callister ME; Sasieni P; Christodoulou E; Kaaks R; Johansson M; Carvalho AL; Vaccarella S; Robbins HA
Int J Cancer; 2022 Nov; 151(9):1491-1501. PubMed ID: 35809038
[TBL] [Abstract][Full Text] [Related]
12. Opportunistic Screening With Low-Dose Computed Tomography and Lung Cancer Mortality in China.
Wang L; Qi Y; Liu A; Guo X; Sun S; Zhang L; Ji H; Liu G; Zhao H; Jiang Y; Li J; Song C; Yu X; Yang L; Yu J; Feng H; Yang F; Xue F
JAMA Netw Open; 2023 Dec; 6(12):e2347176. PubMed ID: 38085543
[TBL] [Abstract][Full Text] [Related]
13. Use of lung cancer screening tests in the United States: results from the 2010 National Health Interview Survey.
Doria-Rose VP; White MC; Klabunde CN; Nadel MR; Richards TB; McNeel TS; Rodriguez JL; Marcus PM
Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1049-59. PubMed ID: 22573798
[TBL] [Abstract][Full Text] [Related]
14. Duration of lead time in screening for lung cancer.
Benbassat J
BMC Pulm Med; 2021 Jan; 21(1):4. PubMed ID: 33407288
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of a single low-dose computed tomography screening for lung cancer: A population-based perspective cohort study in China.
Yu Z; Ni P; Yu H; Zuo T; Liu Y; Wang D
Int J Cancer; 2024 Feb; 154(4):659-669. PubMed ID: 37819155
[TBL] [Abstract][Full Text] [Related]
16. Author response to "lack of benefit from low dose computed tomography in screening for lung cancer".
Huang KL; Wang SY; Lu WC; Chang YH; Su J; Lu YT
BMC Pulm Med; 2020 Aug; 20(1):226. PubMed ID: 32847562
[TBL] [Abstract][Full Text] [Related]
17. Overdiagnosis in lung cancer screening.
Callister MEJ; Sasieni P; Robbins HA
Lancet Respir Med; 2021 Jan; 9(1):7-9. PubMed ID: 33412118
[No Abstract] [Full Text] [Related]
18. [Lung cancer screening: new frontiers].
Kondrashova R; Vogel-Claussen J
Radiologie (Heidelb); 2024 Jun; 64(6):456-462. PubMed ID: 38772915
[TBL] [Abstract][Full Text] [Related]
19. A mathematical model of case-ascertainment bias: Applied to case-control studies nested within a randomized screening trial.
Jansen RJ; Alexander BH; Hayes RB; Miller AB; Wacholder S; Church TR
PLoS One; 2018; 13(3):e0194608. PubMed ID: 29554151
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of the characteristics associated with recall rates, detection rates and positive predictive values of computed tomography screening for lung cancer.
Seigneurin A; Field JK; Gachet A; Duffy SW
Ann Oncol; 2014 Apr; 25(4):781-791. PubMed ID: 24297084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
